Abstract
Somatic gene therapy is supposed to cure life-threatening hematopoietic disorders but is limited by unstable transgene expression. Efficient gene transfer to hematopoietic progenitor cells does not ensure long-term gene expression. It would therefore be advantageous if the expression of transgenes could be restored in bone marrow. Transfer of drug resistance genes such as the multidrug resistance (MDR1) or mutated dihydrofolate reductase (DHFR) genes to hematopoietic cells protects them from the toxicity of anticancer drugs. In addition, transduced cells obtain a selective growth advantage in the presence of anticancer drugs. This can be used to introduce and enrich otherwise non-selectable genes by cotransfer to target cells. Bicistronic vectors have been constructed for coexpression of drug resistance genes and non-selectable, therapeutic genes with the use of an internal ribosomal entry-site (IRES). With the use of bicistronic vectors, expression and function of therapeutic genes hav e been increased in tissue culture and in animal models. Further preclinical investigations are needed to identify optimal conditions for selection.
Keywords: Hematopoietic Cells, Transgene Expression
Current Gene Therapy
Title: Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
Volume: 2 Issue: 2
Author(s): Thomas Licht and Chrisitian Peschel
Affiliation:
Keywords: Hematopoietic Cells, Transgene Expression
Abstract: Somatic gene therapy is supposed to cure life-threatening hematopoietic disorders but is limited by unstable transgene expression. Efficient gene transfer to hematopoietic progenitor cells does not ensure long-term gene expression. It would therefore be advantageous if the expression of transgenes could be restored in bone marrow. Transfer of drug resistance genes such as the multidrug resistance (MDR1) or mutated dihydrofolate reductase (DHFR) genes to hematopoietic cells protects them from the toxicity of anticancer drugs. In addition, transduced cells obtain a selective growth advantage in the presence of anticancer drugs. This can be used to introduce and enrich otherwise non-selectable genes by cotransfer to target cells. Bicistronic vectors have been constructed for coexpression of drug resistance genes and non-selectable, therapeutic genes with the use of an internal ribosomal entry-site (IRES). With the use of bicistronic vectors, expression and function of therapeutic genes hav e been increased in tissue culture and in animal models. Further preclinical investigations are needed to identify optimal conditions for selection.
Export Options
About this article
Cite this article as:
Licht Thomas and Peschel Chrisitian, Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes, Current Gene Therapy 2002; 2 (2) . https://dx.doi.org/10.2174/1566523024605636
DOI https://dx.doi.org/10.2174/1566523024605636 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microbial Metabolomics
Current Genomics Transendothelial Migration of Monocytes: The Underlying Molecular Mechanisms and Consequences of HIV-1 Infection
Current HIV Research Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway
Anti-Cancer Agents in Medicinal Chemistry The Design and Synthesis of Novel Phenothiazine Derivatives as Potential Cytotoxic Agents
Letters in Drug Design & Discovery Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery Potential Minor Haplotypes of CYP2D6 in the Japanese Population
Drug Metabolism Letters New Biomarkers for Colon Cancer Diagnosis: A Review of Recent Patents
Recent Patents on Biomarkers Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia
Current Pharmaceutical Design Soft Bipolar Spectrum and Staging in Bipolar Disorder
Current Psychiatry Reviews Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature
Current Drug Targets Peptide modules for overcoming barriers of nucleic acids transport to cells
Current Topics in Medicinal Chemistry Cancer Metastasis as Disrupted Developmental Phenotype
Current Genomics Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Current Medicinal Chemistry Tetrazole Derivatives as Promising Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Bamboo a Supplement to Human Health: A Comprehensive Review on its Ethnopharmacology, Phytochemistry, and Pharmacological Activity
The Natural Products Journal Protein Kinase Homology Models: Recent Developments and Results
Current Medicinal Chemistry Nanoparticles for Gene Delivery: A Brief Patent Review
Recent Patents on Drug Delivery & Formulation Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy